Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Kampevold Larsen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 1, 2010
[A young man with acute, generalised oedema]Trond Engjom, Kristin Kampevold Larsen, Oddbjørn Hove, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patientsRannveig Skrunes, Einar Svarstad, Kristin Kampevold Larsen, et al.
Nephron|August 30, 2017
Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid DepositsEinar Svarstad, Sabine Leh, Rannveig Skrunes, et al.
Clinics and Practice|January 14, 2020
Severe nephritis as initial sign of Waldenström's macroglobulinemiaThomas Knoop, Kristin Kampevold Larsen, Friedemann Leh, et al.
Journal of the American Society of Nephrology : JASN|January 1, 2013
Agalsidase benefits renal histology in young patients with Fabry diseaseCamilla Tøndel, Leif Bostad, Kristin Kampevold Larsen, et al.
Nephron|December 23, 2014
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuriaCamilla Tøndel, Takahiro Kanai, Kristin Kampevold Larsen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 20, 2017
Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry DiseaseRannveig Skrunes, Camilla Tøndel, Sabine Leh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 1, 2010
[A young man with acute, generalised oedema]Trond Engjom, Kristin Kampevold Larsen, Oddbjørn Hove, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patientsRannveig Skrunes, Einar Svarstad, Kristin Kampevold Larsen, et al.
Nephron|August 30, 2017
Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid DepositsEinar Svarstad, Sabine Leh, Rannveig Skrunes, et al.
Clinics and Practice|January 14, 2020
Severe nephritis as initial sign of Waldenström's macroglobulinemiaThomas Knoop, Kristin Kampevold Larsen, Friedemann Leh, et al.
Journal of the American Society of Nephrology : JASN|January 1, 2013
Agalsidase benefits renal histology in young patients with Fabry diseaseCamilla Tøndel, Leif Bostad, Kristin Kampevold Larsen, et al.
Nephron|December 23, 2014
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuriaCamilla Tøndel, Takahiro Kanai, Kristin Kampevold Larsen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 20, 2017
Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry DiseaseRannveig Skrunes, Camilla Tøndel, Sabine Leh, et al.
Pageof 1